NYSE American - Delayed Quote USD

Cryo-Cell International, Inc. (CCEL)

Compare
7.40
+0.15
+(2.07%)
At close: January 14 at 3:56:43 PM EST
Currency in USD All numbers in thousands
Breakdown
TTM
11/30/2023
11/30/2022
11/30/2021
11/30/2020
Total Revenue
31,838.48
31,343.70
30,336.75
28,884.90
31,147.59
Cost of Revenue
8,386.64
8,442.31
8,792.36
8,989.74
9,657.44
Gross Profit
23,451.84
22,901.39
21,544.39
19,895.17
21,490.15
Operating Expense
19,854.15
19,411.20
17,084.59
15,494.92
14,484.52
Operating Income
3,597.69
3,490.19
4,459.80
4,400.25
7,005.63
Net Non Operating Interest Income Expense
-950.17
-1,236.79
-1,521.77
-1,378.93
-1,544.02
Other Income Expense
-14,994.03
-15,617.89
380.92
-410.09
-422.29
Pretax Income
-12,346.50
-13,364.50
3,318.95
2,611.23
5,039.32
Tax Provision
-3,420.20
-3,842.83
547.54
527.71
1,414.73
Net Income Common Stockholders
-8,926.31
-9,521.67
2,771.41
2,083.52
3,624.60
Diluted NI Available to Com Stockholders
-8,926.31
-9,521.67
2,771.41
2,083.52
3,624.60
Basic EPS
-1.06
-1.14
0.33
0.26
0.48
Diluted EPS
-1.07
-1.14
0.33
0.25
0.45
Basic Average Shares
8,062.16
8,340.84
8,465.57
8,137.34
7,544.49
Diluted Average Shares
8,062.16
8,340.84
8,483.99
8,361.72
8,140.18
Total Operating Income as Reported
-12,573.51
-12,304.03
4,024.47
4,018.23
7,661.60
Total Expenses
28,240.79
27,853.51
25,876.95
24,484.65
24,141.96
Net Income from Continuing & Discontinued Operation
-8,926.31
-9,521.67
2,771.41
2,083.52
3,624.60
Normalized Income
1,914.97
1,607.90
2,454.74
2,410.82
3,929.29
Interest Expense
950.17
1,236.79
1,521.77
1,378.93
1,544.02
Net Interest Income
-950.17
-1,236.79
-1,521.77
-1,378.93
-1,544.02
EBIT
-11,396.34
-12,127.70
4,840.72
3,990.16
6,583.34
EBITDA
-10,304.28
-10,417.29
6,650.06
5,316.55
7,219.32
Reconciled Cost of Revenue
7,863.15
7,856.13
8,102.54
8,498.19
9,187.90
Reconciled Depreciation
1,092.06
1,710.41
1,809.34
1,326.39
635.98
Net Income from Continuing Operation Net Minority Interest
-8,926.31
-9,521.67
2,771.41
2,083.52
3,624.60
Total Unusual Items Excluding Goodwill
-14,995.21
-15,621.33
379.24
-410.19
-423.06
Total Unusual Items
-14,995.21
-15,621.33
379.24
-410.19
-423.06
Normalized EBITDA
4,690.93
5,204.04
6,270.82
5,726.74
7,642.38
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-4,153.93
-4,491.76
62.57
-82.90
-118.37
11/30/2020 - 4/4/1994

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers